A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.
A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.
Recruiting · NCT07555392 · Registry updated 2026-04-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age. | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Recruiting | Phase 2 / Phase 3 | 2026-04-29 | NCT07555392 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bharat Biotech International Limited | 3 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AIIMS Rishikesh Department of Community Medicine | Rishikesh | India | 1 |
| All India Institute of Medical Sciences | Raipur | India | 1 |
| All India Institute of Medical Sciences | Patna | India | 1 |
| All India Institute of Medical Sciences | Guwahati | India | 1 |
| Guru Teg Bahadur Hospital | Delhi | India | 1 |
| IMS & SUM Hospital bhubaneshwar Institute of Medical Sciences & SUM Hospital | Bhubaneswar | India | 1 |
| Jawahar Lal Nehru Medical College | Ajmer | India | 3 |
| PGIMS | Rohtak | India | 1 |
| Redkar Hospital and Research Centre | Mumbai | India | 1 |
| Sardar Patel Medical College | Bikaner | India | 1 |